Bharati Kochar Ms (Bharati Kochar)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Affordable Care Act

Ulcerative Colitis

Top Venues

Inflammatory bowel diseases

Digestive diseases and sciences

Clinical and translational gastroenterology

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Alison Rusher, Elizabeth Araka, Ashwin N Ananthakrishnan, Christine Seel Ritchie, Bharati Kochar Ms
IBD Is Like a Tree: Reflections From Older Adults With Inflammatory Bowel Disease. Inflammatory bowel diseases (2024)
Bharati Kochar Ms, Alison Rusher, Elizabeth Araka, Rachel Glasser, Jennifer Lai, Christine Ritchie, Ashwin N Ananthakrishnan
Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases. Digestive diseases and sciences 69 (3) (2024)
Victoria Gsenger, Adriana Rodriguez, Elizabeth Araka, Fouzia Oza, Hany Eskarous, Bharati Kochar Ms, Ashwin N Ananthakrishnan
A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease. Inflammatory bowel diseases (2024)
Bharati Kochar Ms, Alison Rusher, Elizabeth Araka, Rachel Glasser, Jennifer Lai, Christine Ritchie, Ashwin N Ananthakrishnan
Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases. Digestive diseases and sciences 69 (3) (2024)
Bharati Kochar Ms, Alison Rusher, Elizabeth Araka, Rachel Glasser, Jennifer Lai, Christine Ritchie, Ashwin N Ananthakrishnan
Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases. Digestive diseases and sciences (2024)
Bharati Kochar Ms, Alison Rusher, Elizabeth Araka, Rachel Glasser, Jennifer Lai, Christine Ritchie, Ashwin N Ananthakrishnan
Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases. Digestive diseases and sciences (2024)
Kush Fansiwala, Alison Rusher, Brandon Shore, Hans H Herfarth, Edward Barnes, Bharati Kochar Ms, Shannon Chang
Oral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn's Disease. Inflammatory bowel diseases (2023)
Kush Fansiwala, Alison Rusher, Brandon Shore, Hans H Herfarth, Edward Barnes, Bharati Kochar Ms, Shannon Chang
Oral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn's Disease. Inflammatory bowel diseases (2023)
Taylor Boyd, Elizabeth Bonareri Araka, Bharati Kochar Ms, Ashwin N Ananthakrishnan
Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis. Journal of Crohn's & colitis (2023)
Olivia Kahn-Boesel, Sandhya Cauta, Nneka N Ufere, Ashwin N Ananthakrishnan, Bharati Kochar Ms
A Narrative Review of Financial Burden, Distress and Toxicity of Inflammatory Bowel Diseases in the United States. The American journal of gastroenterology (2023)
Bharati Kochar Ms, Nneka N Ufere, Christine S Ritchie, Jennifer C Lai
The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis. Clinical and translational gastroenterology 13 (1) (2022)
Bharati Kochar Ms, Lakshman Kalasapudi, Nneka N Ufere, Ryan D Nipp, Ashwin N Ananthakrishnan, Christine S Ritchie
Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases. Inflammatory bowel diseases 27 (9) (2022)
Bharati Kochar Ms, Ariela R Orkaby, Ashwin N Ananthakrishnan, Christine S Ritchie
Frailty in inflammatory bowel diseases: an emerging concept. Therapeutic advances in gastroenterology 14 (2021)
Bharati Kochar Ms, Yue Jiang, Wenli Chen, Yuting Bu, Edward L Barnes, Millie D Long
Home Infusions for Inflammatory Bowel Disease Are Safe: US Experience and Patient Perspectives. Crohn's & colitis 360 3 (3) (2021)
Aaron B Mendelsohn, Young Hee Nam, James Marshall, Cara L McDermott, Bharati Kochar Ms, Michael D Kappelman, Jeffrey S Brown, Catherine M Lockhart
Utilization patterns and characteristics of users of biologic anti-inflammatory agents in a large, US commercially insured population. Pharmacology research & perspectives 9 (1) (2021)